Search results
Results from the Tech24 Deals Content Network
The Long Beach Department of Health and Human Services on Wednesday began offering the new boosters at its city-run vaccine clinics. The city’s schedule can be found on its website, where ...
Rite Aid on Wednesday said it expected to have the updated vaccine in stores soon. Customers can begin scheduling their appointments online Friday. Customers can begin scheduling their ...
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. [9] Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. [9] [10] The vaccines are between 85 and 100% effective for at least two years. [9] They result in a decrease in meningitis and ...
Berger did eventually get a booster shot that day, just not at Rite Aid. He got it at the Albertsons pharmacy on 16th and State streets, which he called a “great experience.” He said the ...
Neisseria meningitidis, often referred to as the meningococcus, is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia, a life-threatening sepsis. The bacterium is referred to as a coccus because it is round, and more specifically a diplococcus because of its tendency to form ...
Meningococcal disease describes infections caused by the bacterium Neisseria meningitidis (also termed meningococcus). [1] It has a high mortality rate if untreated but is vaccine-preventable. [2] While best known as a cause of meningitis, it can also result in sepsis, which is an even more damaging and dangerous condition.
NmVac4-A/C/Y/W-135. NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during ...
The first-of-its-kind shot addresses the five most common causes of meningococcal disease, Pfizer says. Vaccine aimed at preventing meningitis in kids approved by FDA. What happens next?